Gene-Targeted Immunotherapy Boosts Survival for Some Colon Cancer Patients
MONDAY, June 3, 2024 (HealthDay News) — There’s potential good news for a sizable minority of people battling advanced colon cancer. Doctors in Britain say that an immunotherapy drug, given before surgery, can help many more patients with a specific genetic profile stay cancer-free long term. The finding pertains toContinue Reading